FI913446L - Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä - Google Patents

Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä Download PDF

Info

Publication number: FI913446L
Authority: FI; Finland
Prior art keywords: phenylpyrazolo; dihydropyridazin; pyridines; oxo; substituted
Prior art date: 1990-07-18

Application number

FI913446A

Other languages

English (en)

Swedish (sv)

Other versions

FI96688B (fi

FI913446A0 (fi

FI96688C (fi

Inventor

Youichi Shiokawa

Atsushi Akahane

Hirohito Katayama

Takafumi Mitsunaga

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-18

Filing date

1991-07-17

Publication date

1992-01-19

1991-07-17 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1991-07-17 Publication of FI913446A0 publication Critical patent/FI913446A0/fi

1992-01-19 Publication of FI913446L publication Critical patent/FI913446L/fi

1996-04-30 Publication of FI96688B publication Critical patent/FI96688B/fi

1996-08-12 Application granted granted Critical

1996-08-12 Publication of FI96688C publication Critical patent/FI96688C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

FI913446A 1990-07-18 1991-07-17 Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä FI96688C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909015764A GB9015764D0 (en)	1990-07-18	1990-07-18	Pyrazolopyridine compound and processes for preparation thereof
GB9015764		1990-07-18

Publications (4)

Publication Number	Publication Date
FI913446A0 FI913446A0 (fi)	1991-07-17
FI913446L true FI913446L (fi)	1992-01-19
FI96688B FI96688B (fi)	1996-04-30
FI96688C FI96688C (fi)	1996-08-12

Family

ID=10679258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI913446A FI96688C (fi)	1990-07-18	1991-07-17	Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä

Country Status (20)

Country	Link
US (1)	US5204346A (fi)
EP (1)	EP0467248B1 (fi)
JP (1)	JP3123562B2 (fi)
KR (1)	KR100219957B1 (fi)
CN (1)	CN1042730C (fi)
AT (1)	ATE172731T1 (fi)
AU (1)	AU651353B2 (fi)
CA (1)	CA2047283C (fi)
DE (1)	DE69130412T2 (fi)
DK (1)	DK0467248T3 (fi)
ES (1)	ES2121760T3 (fi)
FI (1)	FI96688C (fi)
GB (1)	GB9015764D0 (fi)
HU (1)	HU218666B (fi)
IE (1)	IE912427A1 (fi)
IL (1)	IL98872A (fi)
NO (1)	NO178697C (fi)
PH (1)	PH30486A (fi)
PT (1)	PT98358B (fi)
ZA (1)	ZA915376B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5338743A (en) *	1988-06-06	1994-08-16	Fujisawa Pharmaceutical Co., Ltd.	New use of the adenosine antagonist
CA2060138A1 (en) *	1991-01-29	1992-07-30	Youichi Shiokawa	New use of the adenosine antagonist
DE4237656A1 (de) *	1992-06-13	1993-12-16	Merck Patent Gmbh	Benzimidazolderivate
WO1995018128A1 (en) *	1993-12-29	1995-07-06	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine adenosine antagonists
US6214843B1 (en) *	1996-04-25	2001-04-10	Fujitsawa Pharmaceutical Co., Ltd.	Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) *	1996-07-18	1996-08-08	Fujisawa Pharmaceutical Co., Ltd.	New compound
AU733034B2 (en) *	1996-07-18	2001-05-03	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
EP0989129B1 (en) *	1996-10-04	2002-12-11	Kyorin Pharmaceutical Co., Ltd.	Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof
US6303624B1 (en)	1997-03-18	2001-10-16	Fujisawa Pharmaceutical Co., Ltd.	Preventives and remedies for hyperphosphatemia
DE69816651T2 (de)	1997-09-05	2004-04-01	Glaxo Group Ltd., Greenford	2,3-diaryl-pyrazolo[1,5-b]pyridazin derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
US6060481A (en) *	1998-05-28	2000-05-09	The Penn State Research Foundation	Method for improving insulin sensitivity using an adenosine receptor antagonist
CA2333947C (en) *	1998-06-01	2010-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
WO1999067239A1 (en) *	1998-06-22	1999-12-29	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds and medicinal uses thereof
DE69919887T2 (de)	1998-11-03	2005-09-15	Glaxo Group Ltd., Greenford	Pyrazolopyridin derivative als selektive cox-2 inhibitoren
AU2661400A (en)	1999-02-27	2000-09-21	Glaxo Group Limited	Pyrazolopyridines
US20040152659A1 (en) *	1999-05-12	2004-08-05	Fujisawa Pharmaceutical Co. Ltd.	Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
AUPQ441499A0 (en) *	1999-12-02	2000-01-06	Fujisawa Pharmaceutical Co., Ltd.	Novel compound
GB9930358D0 (en)	1999-12-22	2000-02-09	Glaxo Group Ltd	Process for the preparation of chemical compounds
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
AUPQ969800A0 (en) *	2000-08-28	2000-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
DE60112609T2 (de)	2000-12-15	2006-01-19	Glaxo Group Ltd., Greenford	Pyrazolopyridine
US7163940B2 (en)	2000-12-15	2007-01-16	Smithkline Beecham Corporation	Pyrazolopyridinyl pyrimidine therapeutic compounds
WO2002072581A2 (en)	2001-03-08	2002-09-19	Smithkline Beecham Corporation	Pyrazolopyriadine derivatives
WO2002078701A1 (en) *	2001-03-30	2002-10-10	Smithkline Beecham Corporation	Use of pyrazolopyridines as therapeutic compounds
JP4237497B2 (ja)	2001-03-30	2009-03-11	スミスクラインビーチャムコーポレーション	ピラゾロピリジン類、その調製方法及びその治療用化合物としての使用
JP4219171B2 (ja) *	2001-04-10	2009-02-04	スミスクラインビーチャムコーポレーション	抗ウイルス性ピラゾロピリジン化合物
JP2004527560A (ja)	2001-04-27	2004-09-09	スミスクラインビーチャムコーポレーション	ピラゾロ［１，５−α］ピリジン誘導体
US6756498B2 (en)	2001-04-27	2004-06-29	Smithkline Beecham Corporation	Process for the preparation of chemical compounds
AUPR548601A0 (en)	2001-06-06	2001-06-28	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyrazinecompound and pharmaceutical use thereof
WO2003000689A1 (en)	2001-06-21	2003-01-03	Smithkline Beecham Corporation	Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
WO2003022845A1 (en) *	2001-09-07	2003-03-20	Smithkline Beecham Corporation	Pyrazolo-pyridines for the treatment of herpes infections
WO2003031446A1 (en) *	2001-10-05	2003-04-17	Smithkline Beecham Corporation	Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
JP2005516916A (ja) *	2001-12-11	2005-06-09	スミスクラインビーチャムコーポレーション	抗ヘルペス薬としてのピラゾロ−ピリジン誘導体
EP1546148A1 (en) *	2002-10-03	2005-06-29	SmithKline Beecham Corporation	Therapeutic compounds based on pyrazolopyridine derivatives
UA103319C2 (en)	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds
EP2324028A2 (en) *	2008-08-04	2011-05-25	AstraZeneca AB	Therapeutic agents 414
AU2020240059B2 (en) *	2019-03-20	2025-10-23	Gfb (Abc), Llc	Pyridazinones and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4024255A (en) *	1973-04-05	1977-05-17	Allen & Hanburys Limited	Tetrazole containing naphthyridine-3-carboxamides
US4304777A (en) *	1979-08-30	1981-12-08	Sterling Drug Inc.	6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
JPS5826802A (ja) *	1981-08-10	1983-02-17	Sankyo Co Ltd	農園芸用殺菌剤
US4666902A (en) *	1983-06-20	1987-05-19	Cassella Aktiengesellschaft	Tetrahydropyridazinone derivatives, processes for their preparation and their use
HU195645B (en) *	1985-10-30	1988-06-28	Gyogyszerkutato Intezet	Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
JPH0710865B2 (ja) *	1987-06-26	1995-02-08	日本バイエルアグロケム株式会社	ニトロ置換ヘテロ環式化合物及び殺虫剤
GB8901423D0 (en) *	1989-01-23	1989-03-15	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof

1990
- 1990-07-18 GB GB909015764A patent/GB9015764D0/en active Pending
1991
- 1991-07-09 PH PH42760A patent/PH30486A/en unknown
- 1991-07-10 ZA ZA915376A patent/ZA915376B/xx unknown
- 1991-07-11 IE IE242791A patent/IE912427A1/en not_active Application Discontinuation
- 1991-07-13 ES ES91111715T patent/ES2121760T3/es not_active Expired - Lifetime
- 1991-07-13 DK DK91111715T patent/DK0467248T3/da active
- 1991-07-13 EP EP91111715A patent/EP0467248B1/en not_active Expired - Lifetime
- 1991-07-13 AT AT91111715T patent/ATE172731T1/de not_active IP Right Cessation
- 1991-07-13 DE DE69130412T patent/DE69130412T2/de not_active Expired - Fee Related
- 1991-07-15 US US07/729,688 patent/US5204346A/en not_active Expired - Fee Related
- 1991-07-16 AU AU80468/91A patent/AU651353B2/en not_active Ceased
- 1991-07-16 JP JP03268125A patent/JP3123562B2/ja not_active Expired - Fee Related
- 1991-07-17 CN CN91105592A patent/CN1042730C/zh not_active Expired - Fee Related
- 1991-07-17 FI FI913446A patent/FI96688C/fi active
- 1991-07-17 IL IL9887291A patent/IL98872A/en not_active IP Right Cessation
- 1991-07-17 PT PT98358A patent/PT98358B/pt not_active IP Right Cessation
- 1991-07-17 CA CA002047283A patent/CA2047283C/en not_active Expired - Fee Related
- 1991-07-17 NO NO912805A patent/NO178697C/no unknown
- 1991-07-17 HU HU397/91A patent/HU218666B/hu not_active IP Right Cessation
- 1991-07-18 KR KR1019910012195A patent/KR100219957B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE172731T1 (de)	1998-11-15
ZA915376B (en)	1992-04-29
FI96688B (fi)	1996-04-30
FI913446A0 (fi)	1991-07-17
EP0467248A2 (en)	1992-01-22
CA2047283C (en)	2002-07-02
DE69130412D1 (de)	1998-12-03
NO178697C (no)	1996-05-15
HUT58735A (en)	1992-03-30
GB9015764D0 (en)	1990-09-05
DE69130412T2 (de)	1999-04-22
IL98872A (en)	1996-12-05
PT98358A (pt)	1992-05-29
NO912805L (no)	1992-01-20
FI96688C (fi)	1996-08-12
PH30486A (en)	1997-05-28
HU218666B (hu)	2000-10-28
ES2121760T3 (es)	1998-12-16
AU651353B2 (en)	1994-07-21
KR920002603A (ko)	1992-02-28
JP3123562B2 (ja)	2001-01-15
AU8046891A (en)	1992-01-23
IE912427A1 (en)	1992-01-29
NO912805D0 (no)	1991-07-17
PT98358B (pt)	1999-01-29
NO178697B (no)	1996-02-05
US5204346A (en)	1993-04-20
JPH04253978A (ja)	1992-09-09
CN1042730C (zh)	1999-03-31
IL98872A0 (en)	1992-07-15
CA2047283A1 (en)	1992-01-19
EP0467248B1 (en)	1998-10-28
EP0467248A3 (en)	1992-03-11
DK0467248T3 (da)	1999-07-05
KR100219957B1 (ko)	1999-09-01
HU912397D0 (en)	1991-12-30
CN1059143A (zh)	1992-03-04

Publication	Publication Date	Title
FI913446L (fi)	1992-01-19	Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
FI890282L (fi)	1989-07-21	Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI883050L (fi)	1988-12-25	Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI890652A7 (fi)	1989-08-11	Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO176759C (no)	1995-05-24	Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI963424L (fi)	1996-09-02	Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
FI905941A7 (fi)	1991-06-07	Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI870903L (fi)	1987-09-08	Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
NO180749C (no)	1997-06-11	Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
FI893170L (fi)	1989-12-29	Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi
FI885153L (fi)	1989-05-13	Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi
FI811525A7 (fi)	1981-11-20	Menetelmä terapeuttisesti vaikuttavien pyridoksinijohdannaisten valmistamiseksi.
NO180084C (no)	1997-02-12	Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
FI930150L (fi)	1993-01-14	Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
FI883603A7 (fi)	1989-02-04	Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
NO178967C (no)	1996-07-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO174959C (no)	1994-08-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI880467A7 (fi)	1988-08-05	Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI924642L (fi)	1992-10-14	Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI890123L (fi)	1989-07-15	Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä
FI884660L (fi)	1989-04-13	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI916058A7 (fi)	1992-06-28	Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi
NO173784C (no)	1994-02-02	Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175976C (no)	1995-01-11	Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI892684L (fi)	1989-12-02	Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi

Legal Events

Date	Code	Title	Description
1996-04-01	BB	Publication of examined application